In the present study, we showed that β-elemene increased the sensitivity to cisplatin and blocked cisplatin-induced ERCC-1 protein expression in resistant human ovarian cancer cells, suggesting that β-elemene enhances cisplatin sensitivity in resistant ovarian cancer cells by decreasing the proficiency of repair of cisplatin-induced DNA damage. The gene discussed is ERCC1; the disease is ovarian cancer.